Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Secondary mitral regurgitation (SMR) is common in patients with heart failure (HF). Although randomized clinical trials have been focused on the treatment of severe SMR, the prognostic role and potential for treatment of moderate SMR cannot be overlooked. The randomized RESHAPE-HF2 trial included patients with moderate and severe SMR with consistent findings in both groups, raising the hypothesis that transcatheter correction of moderate SMR could have beneficial effects, although this needs further investigation. The aim of this review is to describe the prevalence of moderate SMR in patients with HF, its prognostic impact, and discuss current evidence for pharmacologic and interventional management of patients with moderate SMR.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacc.2025.07.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies.
J Am Coll Cardiol
September 2025
Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiologic Sciences and Public Health, University of Brescia, Brescia, Italy. Electronic address:
Secondary mitral regurgitation (SMR) is common in patients with heart failure (HF). Although randomized clinical trials have been focused on the treatment of severe SMR, the prognostic role and potential for treatment of moderate SMR cannot be overlooked. The randomized RESHAPE-HF2 trial included patients with moderate and severe SMR with consistent findings in both groups, raising the hypothesis that transcatheter correction of moderate SMR could have beneficial effects, although this needs further investigation.
View Article and Find Full Text PDFTranscatheter edge-to-edge repair for the management of secondary mitral regurgitation - CRT 2025 Beyond the Guidelines.
Cardiovasc Revasc Med
August 2025
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. Electronic address:
Secondary mitral regurgitation (SMR) remains a prevalent and challenging complication in patients with heart failure (HF), associated with poor prognosis despite optimal guideline-directed medical therapy (GDMT) and cardiac resynchronization therapy. Current American and European guidelines recommend GDMT as first-line therapy, with transcatheter edge-to-edge repair (TEER) reserved for severe symptomatic SMR patients who remain refractory. However, both guidelines preceded the reporting of pivotal randomized controlled trials (RESHAPE-HF2, MATTERHORN, and EFFORT) and emerging evidence in new clinical scenarios.
View Article and Find Full Text PDFImpact of structured multiprofessional rounds on clinical outcomes in a resource-limited intensive care unit: A retrospective study.
Medicine (Baltimore)
August 2025
Department of Medicine, Federal University of Maranhão (UFMA), São Luís, Brazil.
Effective communication among intensive care professionals is essential for patient safety and outcome optimization. Multiprofessional rounds supported by checklists have demonstrated the potential to improve the quality of care, particularly in high-income settings. However, evidence remains limited for low- and middle-income countries (LMICs).
View Article and Find Full Text PDFEffect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening : A Randomized Controlled Trial.
Ann Intern Med
September 2025
Department of Medicine, Indiana University School of Medicine; Indiana University Melvin and Bren Simon Comprehensive Cancer Center; and Regenstrief Institute, Inc., Indianapolis, Indiana (T.F.I.).
Background: Providing personalized risk information to patients and their providers could improve colorectal cancer (CRC) screening.
Objective: To determine whether providing information on patient risk for advanced colorectal neoplasia (ACN; which includes CRC and advanced precancerous lesions) to patients and providers affects screening uptake, and to identify effect moderators.
Design: Randomized controlled trial (2 × 2 factorial design).
Understanding Etiopathogenesis and Clinical Outcomes in Acute Pancreatitis: An Experience From a Tertiary Care Teaching Hospital in Andhra Pradesh.
Cureus
July 2025
General Medicine, Rangaraya Medical College, Kakinada, IND.
Introduction Acute pancreatitis (AP) is a potentially life-threatening inflammatory disorder of the pancreas with a wide spectrum of clinical manifestations. Early identification of disease severity is critical for guiding management and improving outcomes. Prognostic scoring systems such as the Bedside Index for Severity in Acute Pancreatitis (BISAP) and the CT severity index (CTSI) are commonly used to predict disease progression and complications.
View Article and Find Full Text PDF